Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Placeholder Photo
Selena Daniels, PharmD, MS
TEAM LEADERS, CLINICAL OUTCOME ASSESSMENTS STAFF, OND, CDER, FDA
Enhancing Meaningful Engagement on Patient Experience Data in Drug Development
Steve Darnell, PhD
PRINCIPAL SCIENTIST, DNASTAR, INC.
DNASTAR
Madison, Wisconsin, United States
Debanu Das, ACA
CEO, XPOSE THERAPEUTICS INC.
XPose Therapeutics
San Carlos, California, United States
Placeholder Photo
Ebony Dashiell-Aje, PhD
EXECUTIVE DIRECTOR, PATIENT CENTERED OUTCOMES SCIENCE, BIOMARIN
Enhancing Meaningful Engagement on Patient Experience Data in Drug Development
Placeholder Photo
Matt Davidson
CEO, AZORA THERAPEUTICS
Azora Therapeutics
Stephanie Davis
PROGRAM SPECIALIST, NATIONAL INSTITUTES OF HEALTH
NIH Efforts for Supporting Small Business Entrepreneurs from Diverse Backgrounds
Bethesda, Maryland, United States
Michelle Davis
M&A REPORTER, BLOOMBERG NEWS
Fireside Chat with Christopher Viehbacher, President and Chief Executive Officer, Biogen
Monica De Lazzari
ASSOCIATE, DLA PIPER LLP (US)
Theoretical Patent Thickets v. Data-Driven Patent Policy: Are Changes Necessary at the PTO & FDA?
Placeholder Photo
Anthony DeBoer
VP, BUSINESS DEVELOPMENT, SYNAFFIX BV
Synaffix BV
Oss, Netherlands
Daniel DeFabio
CO-FOUNDER, THE DISORDER CHANNEL
The Power of the Patient Voice